American Bio Medica, a biotechnology company, has received notification from the US Patent & Trademark office that it will be granted two new patents; one for its oral fluid drug testing product line and the other for its all inclusive urine point of collection drug test cup product line.
The first patent relates to the testing of a saliva sample for drugs of abuse, more particularly to a device and process which permits the saliva sample to be treated and incubated for a predetermined period of time prior to being introduced to an immunoassay test strip.
The second patent covers the company’s all-inclusive cup product line and relates to an assay device for the testing of liquid samples for determining the presence of undesirable constituents, more particularly to a test device having a container for retaining a liquid sample and test strips within the container for indicating visually the presence of particular drugs of abuse.
With these grants, American Bio Medica’s intellectual property portfolio for its drug of abuse testing line reportedly increases to 10 US patents and 14 foreign patents, in addition to a number of pending patent applications both within the US and internationally.